Live · 20 Sep 2026 SPX 7,650.50 +0.17% NDX 29,644.17 +0.67% VIX 14.81 -4.08% GOLD 4,415.90 +0.37% CL 95.47 -6.32% BTC 81,118.19 +6.17%
NAS100 29,644 +0.67% S&P 7,651 +0.17% GOLD $4,416 +0.37% BTC $81,118 +6.17% VIX 14.81 −4.08% live tape · as of 19:03 UTC
The Screen · Industrials · Aerospace & Defense

Ducommun Incorporated logoDucommun Incorporated

DCO · the NYSE · USD · Market cap $2.5B · 2,130 employees

Ducommun Incorporated provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.

FAIL · Does not pass the screen
168.32 USD

At the last full screen
2026-09-07

Screened 2026-09-07 · the tape above runs as of 19:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its distribution label.

Ducommun Incorporated holds its Distribution at $168.32. Elevated stress, defensive posture warranted, held for 1 days.

As held on the ledger · 2026-09-07
PhaseDistribution · caution
Quantitative stateElevated stress, defensive posture warranted, held for 1 days
Price at the screen$168.32
ValuationN/A trailing · 31.39 forward price to earnings
Values screenFAIL · score 30.0
Beta1.04
The Workings

Five Screens, Shown in Full

Does not pass. Prohibited business activity: Aerospace & Defense

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited business activity: Aerospace & Defense Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

What the Numbers Say It Is Worth

The Fair Value Range

148.10Conservative148.10Base case170.31Growth case 168.32Price

Fair value range in USD, drawn from the 2026-09-07 screen. The gold marker is the market price at the same screen. The price runs 12.0% above the base estimate.

The Street's Range
200.00Street low 209.00Street average 228.00Street high 168.32Price

Third-party analyst targets: 5 covering, consensus None. The average target sits +24% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections
$243$137$31TODAY5y agoPROJECTIONStreet high$228.00 +49%Street avg$209.00 +36%Conservative$148.10 -3%Our fair value$148.10 -3%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-07 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Defense Contractor Trips Ethical Screen at High Price

Every time a fighter jet rolls off the line or a missile guidance system gets upgraded, Ducommun is somewhere in the supply chain turning raw metal and electronics into finished parts. The business sits squarely inside aerospace and defense, which immediately fails our ethical screen. We pass for that reason alone, before the numbers even enter the conversation.

Revenue is growing at 9 percent, yet profit margins sit at minus 3 percent and return on equity is minus 4 percent. The shares trade at 32.9 times forward earnings, well above our fair value of 124.41 against the current 168.47 price. Analyst targets sit higher still, but none of that offsets the prohibited activity that keeps the name off any list we would consider.

The ethical failure is permanent for us, regardless of margin of safety or cyclical recovery hopes. Negative returns and a stretched multiple only reinforce the decision to stay away. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E31.4xexpensive even after accounting for its growth
EPS, trailing-1.25
EPS, forward5.36
Revenue growth+11.8%steady growth
Profit margin-2.5%currently unprofitable
Return on equity-3.0%not currently earning a positive return on equity
FCF yield2.26%
Debt to equity0.48minimal debt: a conservative balance sheet
Current ratio3.36comfortably covers its short-term bills
Beta1.04moves a little more than the market
Short interest, float0.05%
52-week range84.76 - 210.39
Market cap$2.5B
Employees2,130

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

DCO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-08-26 Markup $204.27 +21.3% Entry 5

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 21.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (5 analysts) rates it strong buy, with a mean price target of $164.

2026-07-26 Markup $168.47 +2.4% Entry 4

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (5 analysts) rates it strong buy, with a mean price target of $164.

2026-07-18 Markup $164.54 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 36%. The street (5 analysts) rates it strong buy, with a mean price target of $164.

2026-07-03 Markup $164.54 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Markup $164.54 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in DCO's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming DCO
DatePoliticianPartyTypeAmount
2026-08-26 David Taylor Republican buy 1K–15K
2026-08-26 David Taylor Republican buy 1K–15K
2026-08-26 David Taylor Republican buy 1K–15K
2026-08-26 David Taylor Republican buy 1K–15K
2026-08-26 David Taylor Republican buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $140.68 +9.1% · $1,091 +9.1%
2 months $139.99 +9.6% · $1,096 +9.6%
3 months $125.68 +22.1% · $1,221 +22.1%
6 months $95.11 +61.3% · $1,613 +61.3%
1 year $74.00 +107.4% · $2,074 +107.4%
2 years $58.00 +164.6% · $2,646 +164.6%
3 years $45.77 +235.3% · $3,353 +235.3%
5 years $56.35 +172.3% · $2,723 +172.3%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever DCO does next, these words stay.

Ducommun Incorporated · DCO · Distribution · $168.32
Recorded 2026-09-07 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.